Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Furanix Technologies BV | 8 |
| 2 | Eli Lilly and Co | 6 |
| 3 | Goodyear Tire and Rubber Co | 5 |
| 4 | Disco Corp | 3 |
| 5 | China Tobacco Henan Industrial Co Ltd | 2 |
| 6 | Kissei Pharmaceutical Co Ltd | 2 |
| 7 | Suntory Holdings Ltd | 2 |
| 8 | The University of Texas System | 2 |
| 9 | University of Texas at Austin | 2 |
| 10 | Arakawa Chemical Industries Ltd | 1 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61P | Therapeutic activity (drug indications) | 33 |
| 2 | A61K | Medicinal preparations | 28 |
| 3 | C07D | Heterocyclic compounds | 20 |
| 4 | C08K | Polymer compositions (additives) | 9 |
| 5 | Y02P | Climate change mitigation: production | 9 |
| 6 | C07B | General methods of organic chemistry | 7 |
| 7 | B01J | Chemical/physical processes (e.g. catalysts) | 5 |
| 8 | B60C | 5 | |
| 9 | C07C | Acyclic and carbocyclic compounds | 5 |
| 10 | C08L | Polymer compositions (blends) | 5 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionWho's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Binoy Varghese Cheriyan | Vels University | 2 |
| 2 | Jagan Nadipelly | Texila American University | 2 |
| 3 | Jaikumar Shanmugasundaram | Meenakshi Academy of Higher Education and Research | 2 |
| 4 | Janez Konc | University of Ljubljana | 2 |
| 5 | Jure Stojan | University of Ljubljana | 2 |
| 6 | Katja Krajnc | University of Ljubljana | 2 |
| 7 | Katja Kristan | University of Ljubljana | 2 |
| 8 | Parimala Kathirvelu | Meenakshi Academy of Higher Education and Research | 2 |
| 9 | S. Viswanathan | Meenakshi Academy of Higher Education and Research | 2 |
| 10 | Stanislav Gobec | University of Ljubljana | 2 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Antagonism of Aryl Hydrocarbon Receptor Signaling by 6,2′,4′-Trimethoxyflavone | 2009 | 79 | Toxic Organic Pollutants Impact |
| 5-Methoxyflavone-induced AMPKα activation inhibits NF-κB and P38 MAPK signaling to attenuate influenza A virus-mediated inflammation and lung injury in vitro and in vivo | 2022 | 46 | Peroxisome Proliferator-Activated Receptors |
| Identification of 5-Methoxyflavone as a Novel DNA Polymerase-Beta Inhibitor and Neuroprotective Agent against Beta-Amyloid Toxicity | 2015 | 28 | Alzheimer's disease research and treatments |
| Anti-inflammatory activity of 4′,6,7-trihydroxy-5-methoxyflavone from Fridericia chica (Bonpl.) L.G.Lohmann | 2018 | 27 | Natural product bioactivities and synthesis |
| Phytoestrogens as inhibitors of fungal 17β-hydroxysteroid dehydrogenase | 2005 | 26 | Estrogen and related hormone effects |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular composition and weight of 5-methoxy-2-phenylchromen-4-one?
Which organizations hold the most patents for 5-methoxy-2-phenylchromen-4-one?
What are the primary patent classification areas for compounds related to 5-methoxy-2-phenylchromen-4-one?
What research topics have been published about 5-methoxy-2-phenylchromen-4-one or related compounds?
How has patent activity for 5-methoxy-2-phenylchromen-4-one changed in recent years?